J. Lewis Research, Inc.
South Jordan, Utah, United States
Research institute in South Jordan, Utah
1868 Shields Ln #100, South Jordan, UT 84095
About J. Lewis Research, Inc.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Allergan
2
Sunovion
1
Clinical Trials at J. Lewis Research, Inc.
During the past decade, J. Lewis Research, Inc. conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on
average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Safety and Efficacy Study of Ciclesonide Nasal Aerosol in Subjects 6-11 Years With Perennial Allergic Rhinitis (PAR).
2011-10-01
2012-12-01
Completed
848
12-Week Placebo-controlled Study of Atogepant for the Preventive Treatment of Migraine in Participants With Episodic Migraine
2018-12-14
2020-06-19
Completed
910
Extension Study to Evaluate the Long-Term Safety and Tolerability of Oral Atogepant for the Prevention of Migraine in Participants With Episodic Migraine
2019-05-06
2021-03-31
Completed
685
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at J. Lewis Research, Inc.
According to Clinical.Site data, the most researched conditions in "J. Lewis Research, Inc." are
"Episodic Migraine" (2 trials), "PAR" (1 trials) and "Perennial Allergic Rhinitis" (1 trials). Many other conditions were trialed in "J. Lewis Research, Inc." in a lesser frequency.
Clinical Trials Intervention Types at J. Lewis Research, Inc.
Most popular intervention types in "J. Lewis Research, Inc." are "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Atogepant" (2 trials), "Placebo" (2 trials), "Ciclesonide nasal aerosol 37 mcg" (1 trials) and "ciclesonide nasal aerosol 74 mcg" (1 trials). Other intervention names were less common.
Clinical Trials Genders at J. Lewis Research, Inc.
The vast majority of trials in "J. Lewis Research, Inc." are
3 trials for "All" genders.
Clinical Trials Status at J. Lewis Research, Inc.
Currently, there are NaN active trials in "J. Lewis Research, Inc.".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in J. Lewis Research, Inc.,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in J. Lewis Research, Inc., 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".